Labshake Marketplace

1 - 50 of 2374 N N Dimethyl 4 4 Trimethylsilyl Ethynyl Phenyl Ethynyl Aniline from Protheragen

• Renal disorders, (trimethylsilyl)-N-dimethyl-acetamide/cremophore-induced, in rat

  Cat# AB18725, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB127102, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB125097, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in rat

  Cat# AB30944, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (FVB)

  Cat# AB56373, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (B6D2F1)

  Cat# AB216393, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (B6D2F1)

  Cat# AB208962, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6J)

  Cat# AB82912, Inquire Ask
• Bladder cancer, Trp53 +/- knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB224746, Inquire Ask
• Bladder cancer, Rgs6 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB194822, Inquire Ask
• Bladder cancer, Ccl2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB192304, Inquire Ask
• Bladder cancer, Esr1 knockout/N-butyl-n-(4-hydroxybutil) nitrosamine-induced, in mouse

  Cat# AB134168, Inquire Ask
• Bladder cancer, Rgs6 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB176328, Inquire Ask
• Bladder cancer, Esr1 knockout/N-butyl-n-(4-hydroxybutil) nitrosamine-induced, in mouse

  Cat# AB151929, Inquire Ask
• Bladder cancer, Trp53 +/- knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB194336, Inquire Ask
• Chronic toxicity, Esr1 knockout/N-butyl-n-(4-hydroxybutil) nitrosamine-induced, in mouse

  Cat# AB139245, Inquire Ask
• Bladder cancer, Trp53 +/- knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB199993, Inquire Ask
• Chronic toxicity, Esr1 knockout/N-butyl-n-(4-hydroxybutil) nitrosamine-induced, in mouse

  Cat# AB136244, Inquire Ask
• Bladder cancer, Ccl2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB172630, Inquire Ask
• Bladder cancer, Ar conditional knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB151928, Inquire Ask
• Chronic toxicity, Ar conditional knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB139239, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine/diphtheria toxin-induced, in mouse (Foxp3 DTR)

  Cat# AB176299, Inquire Ask
• Bladder cancer (adverse event), N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in rat (F344/DuCrlCrlj)

  Cat# AB3892, Inquire Ask
• Bladder cancer, Esr2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB60704, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in Treg depleted mouse (C57BL/6)

  Cat# AB67186, Inquire Ask
• Bladder cancer, Rgs6 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB194823, Inquire Ask
• Bladder cancer, Trp53 +/- knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB176338, Inquire Ask
• Bladder cancer (urothelial carcinoma), N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB96315, Inquire Ask
• Bladder cancer, N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in Treg depleted mouse (C57BL/6)

  Cat# AB176298, Inquire Ask
• Bladder cancer, Trp53 +/- knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB67189, Inquire Ask
• Bladder cancer (urothelial carcinoma), Ldlr knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB199975, Inquire Ask
• Bladder cancer, Rgs6 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB176329, Inquire Ask
• Bladder cancer, Esr2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB52103, Inquire Ask
• Chronic toxicity, Esr2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB61970, Inquire Ask
• Bladder cancer (urothelial carcinoma), N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6J)

  Cat# AB81849, Inquire Ask
• Chronic toxicity, Esr2 knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB52227, Inquire Ask
• Bladder cancer (urothelial carcinoma), Ldlr knockout/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB224728, Inquire Ask
• Bladder cancer (adverse event), N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in rat (Fisher 344)

  Cat# AB12277, Inquire Ask
• Bladder cancer, (XIAP-mutated) knockin/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse (C57BL/6)

  Cat# AB95332, Inquire Ask
• Bladder cancer (urothelial carcinoma, transitional cell), N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in rat (Fischer 344)

  Cat# AB12282, Inquire Ask
• Parkinson's disease, N,N-dimethyl-4,4-bipyridinium dichloride/manganese ethylene-bis-dithiocarbamate-induced, in mouse (Swiss albino)

  Cat# AB97422, Inquire Ask
• Bladder cancer, syngeneic graft (G69 (transgenic (Stat3)/N-butyl-n-[4-hydroxybutil] nitrosamine-treated)), in mouse (FVB/NJ)

  Cat# AB228468, Inquire Ask
• Bladder cancer, syngeneic graft (G69 (transgenic (Stat3)/N-butyl-n-[4-hydroxybutil] nitrosamine-treated)), in mouse (FVB/NJ)

  Cat# AB206222, Inquire Ask
• Bladder cancer (urothelial carcinoma), transgenic (Hgf +/-)/Cdk4 (R24C) mutated/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB134157, Inquire Ask
• Bladder cancer (urothelial carcinoma), transgenic (Hgf +/-)/Cdk4 (R24C) mutated/N-butyl-n-[4-hydroxybutil] nitrosamine-induced, in mouse

  Cat# AB151923, Inquire Ask
• Bladder cancer, syngeneic graft (G7 (transgenic (Stat3)/N-butyl-n-[4-hydroxybutil] nitrosamine-treated)), in mouse (FVB/NJ)

  Cat# AB228469, Inquire Ask
• Bladder cancer, syngeneic graft (G7 (transgenic (Stat3)/N-butyl-n-[4-hydroxybutil] nitrosamine-treated)), in mouse (FVB/NJ)

  Cat# AB206223, Inquire Ask
• Cyclin-Dependent Kinase 4 (CDK4) inhibition, Mt1 knockout/N-nitrosodiethylamine-induced, in mouse

  Cat# AB217409, Inquire Ask
• Cyclin-Dependent Kinase 4 (CDK4) inhibition, Mt1 knockout/N-nitrosodiethylamine-induced, in mouse

  Cat# AB209978, Inquire Ask
• Stomach cancer, Isx knockout/N-methyl-N-nitrosourea-induced, in mouse

  Cat# AB177819, Inquire Ask